Stock to Track: Cannabics Pharmaceuticals Inc (CNBX), Earth Science Tech Inc (ETST), CV Sciences Inc (CVSI)

Stock to Track: Cannabics Pharmaceuticals Inc (CNBX), Earth Science Tech Inc (ETST), CV Sciences Inc (CVSI)

Stock to Track: Cannabics Pharmaceuticals Inc (CNBX), Earth Science Tech Inc (ETST), CV Sciences Inc (CVSI)

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) showing dropped of -6.67% and closed at $2.94, after gaining total volume of 419,118.00 shares. Its earnings per share (EPS) is $0.00 and its beta value stands at -15.65 points and has total market capitalization of $344.26 million and a total of 114.12 million outstanding shares.

Cannabics Pharmaceuticals Inc (CNBX) on February 6, 2017 announced it will begin providing personalized cannabinoid anti-tumor tests for cancer patients. The diagnostic tests are based on liquid biopsies of patients suffering from any kind of cancer. The test uses CTC technology that collects cancer cells from patients’ blood samples, and tests their sensitivity to cannabinoid compounds alongside conventional chemotherapy medicine.

The results enable doctors to make better informed decisions by providing personalized patient data as supporting evidence to available medical treatments. Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals said, “Our vision is to embrace the natural medicinal properties of cannabis utilizing the diversity of active compounds to fight cancer in its manifestation in each individual patient”.

Through an exclusive collaboration with Cancer Hope Israel, which specializes in providing a comprehensive check of the effectiveness of chemotherapy and innovative biological medicines, Cannabics will provide its proprietary cannabinoid based compounds to be assessed in their anti-tumor properties.

Earth Science Tech Inc (OTCMKTS:ETST) reported the surge of 10.49% and closed at $1.79, with the total traded volume of 18,538.00 shares. During last trade its minimum price was $1.65 and it gained its highest price of $1.85 and has a total of 40.91 million outstanding shares.

Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, sports, and alternative medicine worldwide. It focuses on non-prescription nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company also provides consulting services to the athletic facilities industry. Its marketing services include direct marketing, search engine optimization, public relations, email marketing, social media marketing, and development of referral programs. In addition, Earth Science Tech, Inc. retails health and wellness brands, as well as sports nutrition and dietary supplement products; and stocks and sells high grade cannabidiol rich hemp oil and products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. The company was incorporated in 2010 and is headquartered in Boca Raton, Florida.

CV Sciences Inc (OTCMKTS:CVSI) decreased -1.22% closed at $0.405 and traded with total volume of 216,636.00 shares, while the average trading remained 555,644.00 shares. During last trade its minimum price was $0.39 and it gained the highest price of $0.41. Its market capitalization was $23.01 million.

CV Sciences Inc (CVSI) on March 13, 2017 announced the launch of the first online education platform designed to enhance its brand education and advocacy through Experticity. Currently over 750 consumer brands, including The North Face, Dyson, and Quiksilver, are working with Experticity to educate and tap into real-life experts (industry professionals, category opinion leaders, online influencers and passionate retail sales associates) to create a new breed of buying experience — one that is informed, genuine and mutually beneficial for retailers and consumers. CV Sciences’ education platform will cover a variety of topics pertaining to hemp, phytocannabinoids, and its industry-dominating consumer products brand, PlusCBD Oil.

A recent study by Experticity has shown that education-based trainings have proven effective at increasing sales, with Experticity members having 22.2 times more buying conversations each week that involve product recommendations than the average person. Eighty-two percent of those who received Experticity member recommendations also ended up purchasing products as a result.

“Investing in retailer education is a practice we know demonstrates results,” states Sarah Syed, Director of Marketing at CV Sciences. “CV Sciences is dedicated to supporting our retailer and wholesale partners by employing methods we know have a broad impact on consumer buying decisions.”

 

 

Leave a reply

0 Comments

There are no comments on this post.

Risk Warning: Investing in digital currencies, stocks, shares and other securities, commodities, currencies and other derivative investment products (e.g. contracts for difference (“CFDs”) is speculative and carries a high level of risk. Each investment is unique and involves unique risks.

CFDs and other derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how an investment works and whether you can afford to take the high risk of losing your money.

Cryptocurrencies can fluctuate widely in prices and are, therefore, not appropriate for all investors. Trading cryptocurrencies is not supervised by any EU regulatory framework. Past performance does not guarantee future results. Any trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Your capital is at risk.

When trading in stocks your capital is at risk.

Past performance is not an indication of future results. Trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Prices may go down as well as up, prices can fluctuate widely, you may be exposed to currency exchange rate fluctuations and you may lose all of or more than the amount you invest. Investing is not suitable for everyone; ensure that you have fully understood the risks and legalities involved. If you are unsure, seek independent financial, legal, tax and/or accounting advice. This website does not provide investment, financial, legal, tax or accounting advice. Some links are affiliate links. For more information please read our full risk warning and disclaimer.